Zhuhai Trinomab Pharmaceutical Co., Ltd.

This study tested a new injection called TNM002 in 240 healthy Chinese adults to see if it can protect against tetanus. Participants received either TNM002, the standard tetanus shot, or a placebo. The main goal was to measure if TNM002 raises antibody levels enough to prevent te…

This study tested a new medicine called TNM001 to see if it can prevent serious lung infections caused by RSV in high-risk babies under 1 year old. About 315 infants received either the medicine or a placebo and were followed for 9 months. The goal was to see if the antibody coul…

This study tested an injection called TNM001 to see if it can prevent serious lung infections caused by RSV in babies under one year old. Over 2,200 infants received either the injection or a placebo. The goal was to reduce the number of babies who get sick enough to need medical…